Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin Effect on Theophylline PK in Chinese Patients
NCT02023554Phase 1Completed
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Dec 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of azithromycin in chronic obstructive pulmonary disease (COPD) and asthma, sponsored by Southern Medical University Zhujiang Hospital. Primary endpoint: Steady-state plasma concentration of theophylline at Day 15. Started Dec 2013; status: completed.
02
Drugs
azithromycin
03
Conditions
chronic obstructive pulmonary disease (COPD)asthma
Beyond the preview
Go deeper on NCT02023554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02023554.